Megan Carey is a Group Leader in the Neuroscience Program at the Champalimaud Center for the Unknown in Lisbon, Portugal. A native of Philadelphia, USA, Megan first became interested in the neural basis of behavior as an undergraduate at Wesleyan University. She received her PhD from the University of California, San Francisco, where her thesis work on the neural mechanisms of motor learning was awarded UCSF’s Krevans Distinguished Dissertation Award. As a Helen Hay Whitney Postdoctoral Fellow at Harvard Medical School, her research focused on cellular mechanisms of neuromodulation and synaptic plasticity.
In 2010 Megan moved to Lisbon, Portugal to start her independent laboratory at the Champalimaud. Her lab combines quantitative behavioral analysis, genetics, and physiology to understand how the brain, and the cerebellum in particular, controls coordinated movement.
Dr. Carey is an International Early Career Scientist of the Howard Hughes Medical Institute and recently received a Starting Grant from the European Research Council. She has served on the organizing committee of a number of international scientific conferences, including the Champalimaud Neuroscience Symposium (2011, 2016), Cosyne (Computational and Systems Neuroscience, Utah, USA, 2016-2017), and the FENS Forum (Copenhagen, Denmark, 2016). Dr. Carey serves on the Open Science panel of the RISE high-level advisory group to the European Commission.